Patents by Inventor CALIFORNIA NORTHSTATE COLLEGE OF PHAR

CALIFORNIA NORTHSTATE COLLEGE OF PHAR has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • FORMULATIONS HAVING AN ALPHA V BETA 3 ANTAGONIST AND AN ALPHA 2 BETA 1 ANTAGONIST FOR ANTI-ANGIONIC THERAPY
    Publication number: 20130225494
    Abstract: The teachings provided herein generally relate to a combination therapy and are directed to pharmaceutical compositions and methods for administering a combination of an ?v?3 antagonist with an ?V?1 antagonist to a subject. The methods are for use in inhibiting, preventing, or reversing angiogenesis, as well as in treating cancer. In some embodiments, the compositions and methods include a combined administration of echistatin and VP12 (ECL12).
    Type: Application
    Filed: November 7, 2012
    Publication date: August 29, 2013
    Applicant: CALIFORNIA NORTHSTATE COLLEGE OF PHARMACY
    Inventor: CALIFORNIA NORTHSTATE COLLEGE OF PHAR
  • FORMULATIONS HAVING AN ANTAGONIST OF ALPHA 5 BETA 1 FOR ANTI-ANGIOGENESIS AND CANCER TREATMENT
    Publication number: 20130225495
    Abstract: The teachings provided herein generally relate to a combination therapy and are directed to pharmaceutical compositions and methods for administering a combination of an ?5?1 antagonist with an ?2?1 antagonist to a subject. The methods are for use in inhibiting, preventing, or reversing angiogenesis, as well as in treating cancer. In some embodiments, the compositions and methods include a combined administration of VLO4 and VP12 (ECL12).
    Type: Application
    Filed: November 7, 2012
    Publication date: August 29, 2013
    Applicant: CALIFORNIA NORTHSTATE COLLEGE OF PHARMACY
    Inventor: CALIFORNIA NORTHSTATE COLLEGE OF PHAR